Literature DB >> 18189192

Estimation of the prevalence of primary Sjögren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study.

A J Haugen1, E Peen, B Hultén, A C Johannessen, J G Brun, A K Halse, H-J Haga.   

Abstract

OBJECTIVE: To estimate the point prevalence of primary Sjögren's syndrome (pSS) in two populations, aged 40-44 and 71-74 years, using two sets of classification criteria.
METHODS: The participating individuals were recruited from the Hordaland Health Study (HUSK) conducted during 1997-99. A total of 18 592 individuals born 1953-57 and 3346 individuals born 1925-27 were sent a questionnaire covering various health-related questions, including four questions about sicca symptoms. Among those answering positive to at least one of the four questions, 99 and 90 individuals born 1953-57 and 1925-27, respectively, were examined further. For diagnosis of pSS two classifications were used, the preliminary European criteria from 1993, and the revised European criteria from 1996.
RESULTS: By using the two classification criteria from 1993 and 1996, the point prevalences were 0.44% [95% confidence interval (CI) 0.34-0.57] and 0.22% (95% CI 0.15-0.32), respectively, for the population group born 1953-57. The corresponding estimates were 3.39% (95% CI 2.77-4.14) and 1.40% (95% CI 1.02-1.92) for the population born 1925-27.
CONCLUSION: The point prevalence of pSS was approximately seven times higher in the elderly population aged 71-74 years compared to individuals aged 40-44 years, regardless of the classification criteria used.

Entities:  

Mesh:

Year:  2008        PMID: 18189192     DOI: 10.1080/03009740701678712

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  23 in total

1.  Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies.

Authors:  Barbara M Segal; Abu N M Nazmul-Hossain; Ketan Patel; Pamela Hughes; Kathy L Moser; Nelson L Rhodus
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-04-16

Review 2.  Sjögren syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  CMAJ       Date:  2014-02-24       Impact factor: 8.262

Review 3.  [Epidemiology of primary Sjörgren's syndrome].

Authors:  G Westhoff; A Zink
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

4.  Tear lipocalin captures exogenous lipid from abnormal corneal surfaces.

Authors:  Ben J Glasgow; Oktay K Gasymov; Adil R Abduragimov; Jamison J Engle; Richard C Casey
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-03       Impact factor: 4.799

Review 5.  Genes and Sjögren's syndrome.

Authors:  Beth L Cobb; Christopher J Lessard; John B Harley; Kathy L Moser
Journal:  Rheum Dis Clin North Am       Date:  2008-11       Impact factor: 2.670

6.  The prevalence of rheumatic diseases in central Greece: a population survey.

Authors:  Ioannis Anagnostopoulos; Elias Zinzaras; Ioannis Alexiou; Aphrodite A Papathanasiou; Evangelos Davas; Athanasios Koutroumpas; Georgia Barouta; Lazaros I Sakkas
Journal:  BMC Musculoskelet Disord       Date:  2010-05-26       Impact factor: 2.362

Review 7.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

Review 8.  Sjögren's syndrome in older patients: aetiology, diagnosis and management.

Authors:  Rada V Moerman; Hendrika Bootsma; Frans G M Kroese; Arjan Vissink
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

9.  Aquaporin gene therapy corrects Sjögren's syndrome phenotype in mice.

Authors:  Zhennan Lai; Hongen Yin; Javier Cabrera-Pérez; Maria C Guimaro; Sandra Afione; Drew G Michael; Patricia Glenton; Ankur Patel; William D Swaim; Changyu Zheng; Cuong Q Nguyen; Fred Nyberg; John A Chiorini
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-02       Impact factor: 11.205

Review 10.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.